Αποτελέσματα Αναζήτησης
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) requested a brief update of the 2018 recommendations on management of hyperglycemia (1,2), based on the important research findings published in 2019, with a particular focus on new data from large cardiovascular outcomes trials (CVOTs).The authors began work on the brief update in July 2019 ...
What is the AC-TH Regimen? our drugs (Doxorubicin, Cyclophosphamide, Paclitaxel and Trastu. umab). This is given for t. How is AC-TH Administered? . iven through four separate injections into your veins (intravenously). For the . irst four to six cycles, you will receive AC every two or three weeks. Followed by 12-weekly injections of Pacl.
G-CSF support (using standard or pegylated form) is required with all cycles of dose dense DOXOrubicin and cycloPHOSphamide. Facilities to treat anaphylaxis MUST be present when the systemic anti-cancer therapy (SACT) is administered.
16 Ιουλ 2016 · 1) Tight glycemic control reduces complications. 2) Type 2 diabetes is a progressive disease. 3) There remain unmet clinical needs: weight gain, hypoglycemia, etc. 4) Adherence and compliance remain issues. 5) Most therapies fail to adequately control postprandial hyperglycemia.
15 Φεβ 2019 · The first-line treatment option, metformin, is safe and fairly well-tolerated, has excellent long-term effectiveness on patient-oriented outcomes, is moderately priced, and has a simple dosing...
17 Ιουλ 2013 · If not at target, stage 1: Start with lifestyle and metformin. If A1C ≥7.5% (10) or ≥9% (9, 10), consider short-term combination therapy or insulin, respectively. Stage 2: If A1C is not at target after 3–6 months of metformin therapy, suggest adding incretin therapy (in relation to BMI).
1 Ιουλ 2012 · Exenatide once weekly (QW), a glucagon-like peptide-1 (GLP-1) receptor agonist, is the first and only glucose-lowering therapy indicated for once-weekly administration with diet and exercise to improve glycemic control in patients with type 2 diabetes.
